secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001100682-23-000025
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO James Foster buys $1M of CRL stock, terminates sell plan
------------------------------------------------------------

- CEO James C. Foster purchased 5,620 shares at average price $178.05 on Nov 14, 2023.
- Total purchase price approximately $1.0 million in open market transactions.
- Terminated Rule 10b5-1 trading plan dated Feb 24, 2023 that allowed sale of up to 112,341 shares.
- Foster cited confidence in strategic direction and long-term growth prospects.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/0001100682-23-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068223000025/crl-20231114.htm
  HTML page:      https://secwatch.observer/filing/0001100682-23-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer